Plasmid Manufacturing scale-up case study: strategy and lessons learned from a well-controlled process resulting in high quality and competitive yield

Imunon Inc. published this content on March 26, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 02, 2026 at 17:25 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]